Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy - PubMed (original) (raw)
Comparative Study
. 2002 Oct 15;186(8):1092-7.
doi: 10.1086/343802. Epub 2002 Sep 20.
Phuong L Nguyen, Esteban Martinez, Cavan Reilly, Jose M Gatell, Andrzej Horban, Elzbieta Bakowska, Baiba Berzins, Remko van Leeuwen, Steven Wolinsky, Ashley T Haase, Robert L Murphy
Affiliations
- PMID: 12355359
- DOI: 10.1086/343802
Comparative Study
Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy
Timothy W Schacker et al. J Infect Dis. 2002.
Abstract
Effective highly active antiretroviral therapy (HAART) for human immunodeficiency virus type 1 is associated with virus suppression and immune reconstitution. However, in some patients, this reconstitution is partial or incomplete because CD4(+) cell counts do not increase significantly. This may be due to damage in the microenvironment of lymphoid tissues (LTs), where CD4(+) T cells reside. To test this hypothesis, LT samples were obtained from 23 patients enrolled in a prospective trial that compared 3 different HAART regimens. Analysis of LT architecture and CD4(+) T cells populations revealed abnormalities in 100% of the LT samples, especially in the follicles, with 43% showing absence, 14% showing regression, and 43% showing hyperplasia. CD4(+) T cell populations were abnormal in 16 (89%) of 18 tissue samples, with 7 (39%) of 18 decreased by >50% of normal levels. These data are consistent with the hypothesis that persistent abnormalities in the microenvironment can influence immune reconstitution and document persistent LT abnormalities with HAART not detected by measures of peripheral CD4(+) T cell count.
Similar articles
- Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S. Guadalupe M, et al. J Virol. 2003 Nov;77(21):11708-17. doi: 10.1128/jvi.77.21.11708-11717.2003. J Virol. 2003. PMID: 14557656 Free PMC article. - Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C, Biasin M, Bandera A, Violin M, Marchetti G, Piacentini L, Vago GL, Balotta C, Moroni M, Franzetti F, Clerici M, Gori A. Tincati C, et al. Antivir Ther. 2009;14(3):321-30. Antivir Ther. 2009. PMID: 19474466 - Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
Costiniuk CT, Angel JB. Costiniuk CT, et al. Mucosal Immunol. 2012 Nov;5(6):596-604. doi: 10.1038/mi.2012.82. Epub 2012 Aug 29. Mucosal Immunol. 2012. PMID: 22929559 Review. - Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group. Antonucci G, et al. Clin Infect Dis. 2005 Jun 15;40(12):e101-9. doi: 10.1086/430445. Epub 2005 May 5. Clin Infect Dis. 2005. PMID: 15909251 - Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
Haase AT. Haase AT. Annu Rev Immunol. 1999;17:625-56. doi: 10.1146/annurev.immunol.17.1.625. Annu Rev Immunol. 1999. PMID: 10358770 Review.
Cited by
- Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era.
Bedimo R. Bedimo R. Curr HIV/AIDS Rep. 2008 Aug;5(3):140-9. doi: 10.1007/s11904-008-0022-4. Curr HIV/AIDS Rep. 2008. PMID: 18627663 Review. - Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection.
Zaunders J, Xu Y, Kent SJ, Koelsch KK, Kelleher AD. Zaunders J, et al. Front Immunol. 2017 May 12;8:495. doi: 10.3389/fimmu.2017.00495. eCollection 2017. Front Immunol. 2017. PMID: 28553284 Free PMC article. Review. - CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis.
Phetsouphanh C, Xu Y, Zaunders J. Phetsouphanh C, et al. Front Immunol. 2015 Jan 6;5:681. doi: 10.3389/fimmu.2014.00681. eCollection 2014. Front Immunol. 2015. PMID: 25610441 Free PMC article. Review. - The immune response to SARS-CoV-2 in people with HIV.
Höft MA, Burgers WA, Riou C. Höft MA, et al. Cell Mol Immunol. 2024 Feb;21(2):184-196. doi: 10.1038/s41423-023-01087-w. Epub 2023 Oct 11. Cell Mol Immunol. 2024. PMID: 37821620 Free PMC article. Review. - HIV cure research: a formidable challenge.
Ananworanich J, Fauci AS. Ananworanich J, et al. J Virus Erad. 2015 Jan 1;1(1):1-3. doi: 10.1016/S2055-6640(20)31152-3. J Virus Erad. 2015. PMID: 27482389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials